DE69434765D1 - Zusammensetzung und methoden bezogen auf dna fehlpaarungsreparaturgene - Google Patents

Zusammensetzung und methoden bezogen auf dna fehlpaarungsreparaturgene

Info

Publication number
DE69434765D1
DE69434765D1 DE69434765T DE69434765T DE69434765D1 DE 69434765 D1 DE69434765 D1 DE 69434765D1 DE 69434765 T DE69434765 T DE 69434765T DE 69434765 T DE69434765 T DE 69434765T DE 69434765 D1 DE69434765 D1 DE 69434765D1
Authority
DE
Germany
Prior art keywords
methods
mistaking
repairs
dna
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69434765T
Other languages
English (en)
Other versions
DE69434765T2 (de
Inventor
Sean M Baker
Roni J Bollag
Richard D Kolodner
C Eric Bronner
Robert M Liskay
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
OREGON HEALTH & SCIENCE UNIVERSITY, PORTLAND, , US
Dana Farber Cancer Institute Inc
Original Assignee
Dana Farber Cancer Institute Inc
Oregon Health Science University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/209,521 external-priority patent/US5922855A/en
Application filed by Dana Farber Cancer Institute Inc, Oregon Health Science University filed Critical Dana Farber Cancer Institute Inc
Application granted granted Critical
Publication of DE69434765D1 publication Critical patent/DE69434765D1/de
Publication of DE69434765T2 publication Critical patent/DE69434765T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
DE69434765T 1993-12-17 1994-12-16 Zusammensetzung und methoden bezogen auf dna fehlpaarungsreparaturgene Expired - Lifetime DE69434765T2 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US16887793A 1993-12-17 1993-12-17
US168877 1993-12-17
US08/209,521 US5922855A (en) 1993-12-17 1994-03-08 Mammalian DNA mismatch repair genes MLH1 and PMS1
US352902 1994-12-09
US08/352,902 US6191268B1 (en) 1993-12-17 1994-12-09 Compositions and methods relating to DNA mismatch repair genes
PCT/US1994/014746 WO1995016793A1 (en) 1993-12-17 1994-12-16 Compositions and methods relating to dna mismatch repair genes
US209521 1998-12-10

Publications (2)

Publication Number Publication Date
DE69434765D1 true DE69434765D1 (de) 2006-07-27
DE69434765T2 DE69434765T2 (de) 2007-05-24

Family

ID=27389577

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69434765T Expired - Lifetime DE69434765T2 (de) 1993-12-17 1994-12-16 Zusammensetzung und methoden bezogen auf dna fehlpaarungsreparaturgene

Country Status (10)

Country Link
US (4) US6191268B1 (de)
EP (1) EP0760867B1 (de)
JP (1) JP4101285B2 (de)
AT (1) ATE330009T1 (de)
AU (1) AU1442495A (de)
CA (1) CA2179285A1 (de)
DE (1) DE69434765T2 (de)
DK (1) DK0760867T3 (de)
ES (1) ES2270424T3 (de)
WO (1) WO1995016793A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6191268B1 (en) * 1993-12-17 2001-02-20 Dana-Farber Cancer Institute Compositions and methods relating to DNA mismatch repair genes
NZ281023A (en) * 1994-01-27 1998-04-27 Human Genome Sciences Inc Human dna mismatch repair proteins and coding sequences
US6380369B1 (en) * 1994-01-27 2002-04-30 Human Genome Sciences, Inc. Human DNA mismatch repair proteins
US6482606B1 (en) * 1994-01-27 2002-11-19 Human Genome Sciences, Inc. Human DNA mismatch repair polynucleotides
AUPM612494A0 (en) * 1994-06-08 1994-06-30 Csl Limited Treatment or prevention of helicobacter infection
JPH0847247A (ja) * 1994-08-05 1996-02-16 Fuji Denki Kogyo Kk Ｄｃ／ｄｃコンバータ回路
CA2223971A1 (en) * 1995-06-07 1996-12-19 Marilee Burrell Antibody detection of mismatch repair proteins
US6294325B1 (en) * 1996-07-05 2001-09-25 The Mount Sinai School Of Medicine Of The City University Of New York Cloning and expression of thermostable multi genes and proteins and uses thereof
WO1999001550A1 (en) 1997-07-03 1999-01-14 Dana-Farber Cancer Institute A method for detection of alterations in msh5
DE19739611A1 (de) * 1997-09-09 1999-03-11 Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh Nucleinsäure-Sequenzen und Verfahren zum Nachweis von Bakterien der Gattung Pseudomonas
DE19747748A1 (de) * 1997-10-29 1999-05-06 Manfred Dr Dr Gross Testverfahren zur Identifizierung von Personen mit defektem Mismatch-Reparatursystem
US6146894A (en) 1998-04-14 2000-11-14 The Johns Hopkins University Method for generating hypermutable organisms
US7148016B1 (en) * 1999-01-14 2006-12-12 Ca*Tx Inc. Immunoassays to detect diseases or disease susceptibility traits
CA2398094C (en) * 2000-02-11 2013-01-08 The Johns Hopkins University Methods for generating hypermutable microbes
DE60039371D1 (de) * 2000-02-18 2008-08-14 Morphotek Inc Methode zur herstellung hypermutabler pflanzen
DK1259628T5 (da) * 2000-02-23 2018-06-14 Univ Johns Hopkins Fremgangsmåde til dannelse af hypermutabel gær
US6677146B1 (en) * 2000-03-28 2004-01-13 Replidyne, Inc. Thermophilic polymerase III holoenzyme
US6825038B2 (en) * 2000-05-12 2004-11-30 The Johns Hopkins University Method for generating hypermutable organisms
IL154099A0 (en) * 2000-07-27 2003-07-31 Univ Delaware A method and kit for enhancing oligonucleotide-mediated gene alteration
US7223598B2 (en) * 2000-11-07 2007-05-29 Morphotek, Inc. Methods for isolating novel antimicrobial agents from hypermutable mammalian cells
US7235643B2 (en) * 2000-11-07 2007-06-26 Morphotek, Inc. Antibodies and methods for generating genetically altered antibodies with high affinity
US6808894B1 (en) 2000-11-07 2004-10-26 Morphotek, Inc. Methods for generating genetically altered antibody producing cell lines with improved antibody characteristics
US6576468B1 (en) 2000-11-07 2003-06-10 Morphotek, Inc. Methods for obtaining microbe-resistant mammalian cells from hypermutable mammalian cells
US6737268B1 (en) 2000-11-14 2004-05-18 Morphotek, Inc. Method for generating genetically altered antigens
US6982169B2 (en) 2001-01-15 2006-01-03 Morphotek, Inc. Chemical inhibitors of mismatch repair
ATE501635T1 (de) * 2001-01-15 2011-04-15 Morphotek Inc Chemische hemmstoffe des mismatch-repair
US20030068808A1 (en) * 2001-07-25 2003-04-10 Nicolaides Nicholas C. Methods for generating antibiotic resistant microbes and novel antibiotics
US20030165940A1 (en) * 2001-12-06 2003-09-04 The Johns Hopkins University Disease detection by digital protein truncation assays
US20040115695A1 (en) * 2002-07-19 2004-06-17 Morphotek Inc. Methods for generating enhanced antibody producing cell lines with improved growth characteristics
US7316903B2 (en) * 2003-03-28 2008-01-08 United States Of America As Represented By The Department Of Health And Human Services Detection of nucleic acid sequence variations using phase Mu transposase
EP1626991A2 (de) * 2003-05-23 2006-02-22 Morphotek, Inc. Anti-alpha-folsäure-rezeptor-tetramer antikörper
US7332584B2 (en) * 2003-12-08 2008-02-19 Morphotek, Inc. Antibodies that specifically bind PMS2
EP1716179A2 (de) * 2004-02-12 2006-11-02 Morphotek, Inc. Monoklonaler antikörper spezifisch für den folatrezeptor alpha
EP1861425B1 (de) * 2005-03-10 2012-05-16 Morphotek, Inc. Anti-mesothelin-antikörper
EP2172487A1 (de) 2005-04-22 2010-04-07 Morphotek Inc. Antikörper mit Immuneffektoraktivität, die in Folatrezeptor alpha-positive Zellen internalisiert werden
CN102296105A (zh) * 2010-06-25 2011-12-28 复旦大学 一种检测mlh1基因突变的方法及其试剂盒
WO2019041045A1 (en) 2017-09-01 2019-03-07 The Hospital For Sick Children PROFILING AND TREATMENT OF HYPERMUTANT CANCER

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5043272A (en) * 1989-04-27 1991-08-27 Life Technologies, Incorporated Amplification of nucleic acid sequences using oligonucleotides of random sequence as primers
WO1993022457A1 (en) * 1992-04-24 1993-11-11 Massachusetts Institute Of Technology Screening for genetic variation
US7229755B1 (en) * 1993-11-17 2007-06-12 Dana Farber Cancer Institute, Inc. Method for detection of alterations in the DNA mismatch repair pathway
WO1995015381A2 (en) * 1993-12-02 1995-06-08 The Johns Hopkins University HUMAN MUTATOR GENE hMSH2 AND HEREDITARY NON POLYPOSIS COLORECTAL CANCER
US6191268B1 (en) * 1993-12-17 2001-02-20 Dana-Farber Cancer Institute Compositions and methods relating to DNA mismatch repair genes
NZ281023A (en) * 1994-01-27 1998-04-27 Human Genome Sciences Inc Human dna mismatch repair proteins and coding sequences

Also Published As

Publication number Publication date
DE69434765T2 (de) 2007-05-24
US6538108B1 (en) 2003-03-25
JPH09512702A (ja) 1997-12-22
CA2179285A1 (en) 1995-06-22
US20030224463A1 (en) 2003-12-04
US6191268B1 (en) 2001-02-20
AU1442495A (en) 1995-07-03
US6165713A (en) 2000-12-26
ES2270424T3 (es) 2007-04-01
ATE330009T1 (de) 2006-07-15
EP0760867A4 (de) 1998-11-25
DK0760867T3 (da) 2006-10-23
JP4101285B2 (ja) 2008-06-18
EP0760867A1 (de) 1997-03-12
EP0760867B1 (de) 2006-06-14
WO1995016793A1 (en) 1995-06-22

Similar Documents

Publication Publication Date Title
DE69434765D1 (de) Zusammensetzung und methoden bezogen auf dna fehlpaarungsreparaturgene
Nagamine et al. A PCR artifact: generation of heteroduplexes.
Detera‐Wadleigh et al. Initial genome scan of the NIMH genetics initiative bipolar pedigrees: chromosomes 4, 7, 9, 18, 19, 20, and 21q
Schilling et al. Allele-specific DNA methylation in mouse strains is mainly determined by cis-acting sequences
Modrich Mismatch repair, genetic stability, and cancer
Amler et al. Amplified N-myc in human neuroblastoma cells is often arranged as clustered tandem repeats of differently recombined DNA
USH2220H1 (en) Identification and mapping of single nucleotide polymorphisms in the human genome
Gershon Bipolar illness and schizophrenia as oligogenic diseases: implications for the future
Gasser et al. Analysis of sequence homogenisation in rDNA arrays of Haemonchus contortus by denaturing gradient gel electrophoresis
WO1999029903A3 (en) Cancer susceptibility mutations of brca1
Yoshino et al. Essential role for gene profiling analysis in the authentication of human cell lines
CN115052993A (zh) 用于检测染色体异常的高分辨率光谱染色体分带的方法
KR101720483B1 (ko) 뱀장어 종 판별용 펩티드핵산(pna) 프로브 세트 및 이를 이용한 뱀장어 종 판별 방법
Zimmerman et al. Exploiting structural differences among heteroduplex molecules to simplify genotyping the DQA1 and DQB1 alleles in human lymphocyte typing
CN101705232A (zh) 猪的snp分子标记及其引物
Ando et al. Detection of 12 germ-line mutations in the adenomatous polyposis coli gene by polymerase chain reaction
Liehr Repetitive elements, heteromorphisms, and copy number variants
Demars et al. Genetic variants within the second intron of the KCNQ1 gene affect CTCF binding and confer a risk of Beckwith–Wiedemann syndrome upon maternal transmission
Okamura et al. Whole-exome sequencing of fibroblast and its iPS cell lines derived from a patient diagnosed with xeroderma pigmentosum
Filipski et al. Structure, function and DNA composition of Saccharomyces cerevisiae chromatin loops
Steube et al. A simple method using β-globin polymerase chain reaction for the species identification of animal cell lines—a progress report
Hutter et al. Use of polymorphisms in the noncoding region of the human mitochondrial genome to identify potential contamination of human leukemia-lymphoma cell lines
Pruvost et al. From genes to phenotypes–Evaluation of two methods for the SNP analysis in archaeological remains: Pyrosequencing and competitive allele specific PCR (KASPar)
Ross et al. DNA typing and forensic science
Yamada et al. A method for identifying allele-specific hydroxymethylation

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: DANA-FARBER CANCER INSTITUTE, BOSTON, MASS., US

Owner name: OREGON HEALTH & SCIENCE UNIVERSITY, PORTLAND, , US